IL37 and myeloid sarcoma: In addition, in some MS patients, a single nucleotide polymorphism of the IL-23 subunit p40 increases the p40 expression and is associated with a younger onset of the disease and single nucleotid polymorphisms of the p19 subunit or the IL23R gene were associated with a higher risk of MS [9, 16].